Adipotide vs CagriSema — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose vasculature, linked to a proapoptotic sequence that triggers cell death in the t...
Calculate Adipotide dose →9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin slows gastric emptying and promotes satiety signaling....
Calculate CagriSema dose →| Parameter | Adipotide | CagriSema |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Preclinical | Phase III |
| Half-Life | - | - |
| Typical Dose | 1 mg/kg body weight | Cagrilintide 2.4 mg + Semaglutide 2.4 mg |
| Frequency | Daily (research cycles) | Once weekly |
| Route | Subcutaneous | Subcutaneous (weekly) |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.